3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
4
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Meningeal Neoplasms
1
Meningeal Carcinomatosis
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiosurgery
12
Temozolomide
10
Radiotherapy
10
Magnetic Resonance Spectroscopy
7
Erlotinib Hydrochloride
6
Bevacizumab
6
Surgical Procedures, Operative
5
Pemetrexed
5
Gefitinib
5
Drug Therapy
5
Carboplatin
5
pyrotinib
4
icotinib
4
aumolertinib
4
Trastuzumab
3
Spermine Synthase
3
Radiation
3
Lomustine
3
Etoposide
3
Dexmedetomidine
3
Chlorotoxin
3
Carmustine
3
osimertinib
2
camrelizumab
2
apatinib
2
Tyrosine Kinase Inhibitors
2
Thiotepa
2
Surveys and Questionnaires
2
Sevoflurane
2
Propofol
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Brain Neoplasms
×
paclitaxel-Angiopep-2 conjugate
×
Clear all
NCT03613181
2023-04-24
ANGLeD
Angiochem Inc
Phase 3
Unknown
150 enrolled